1996

BDF Fund (the predecessor of Vivo Capital) was formed by Dr. Frank Kung and Dr. Edgar Engleman in Palo Alto, United States, focused on biotech venture investments

2000

Early explorations in Asia healthcare market

2007

Established Vivo’s office in China

2015

First standalone venture capital fund, Vivo Innovation Fund I (aka Vivo PANDA Fund)

2016

Raised the firm’s first private equity fund, Vivo Capital Fund VIII, predominantly focused on growth & buyout investments

2018

Spun out dedicated Opportunity Fund, focused on biotech public equity investments

2023

Established presence in Singapore

PRESENT

A multi-stage global investment platform in the healthcare sphere